Insulin-induced insulin receptor substrate-1 degradation is mediated by the proteasome degradation pathway

Diabetes

Volumn 48, Issue 7, 1999, Pages 1359-1364

  Sun, Xiao Jian ^a   Goldberg, Jonathan L ^a   Qiao, Li Ya ^a   Mitchell, John J ^a  

^a UNIVERSITY OF VERMONT COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

INSULIN; INSULIN RECEPTOR SUBSTRATE 1; LACTACYSTIN; PROTEASOME;

ANIMAL CELL; ARTICLE; CONTROLLED STUDY; HORMONE ACTION; HUMAN; HYPERINSULINEMIA; INSULIN RESISTANCE; NONHUMAN; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN DETERMINATION;

1-PHOSPHATIDYLINOSITOL 3-KINASE; ADENOSINE TRIPHOSPHATASES; ANIMALS; CA(2+)-CALMODULIN DEPENDENT PROTEIN KINASE; CHO CELLS; CRICETINAE; CYSTEINE ENDOPEPTIDASES; ENZYME ACTIVATION; HUMANS; INSULIN; INTRACELLULAR SIGNALING PEPTIDES AND PROTEINS; MULTIENZYME COMPLEXES; PHOSPHOPROTEINS; PROTEASOME ENDOPEPTIDASE COMPLEX; PROTEIN KINASE C; RATS; RECEPTOR, INSULIN;

EID: 0000085132     PISSN: 00121797     EISSN: None     Source Type: Journal    
DOI: 10.2337/diabetes.48.7.1359     Document Type: Article

References (44)

1. White MF: The insulin signalling system and the IRS proteins. Diabetologia 40 (Suppl. 2):S2-S17, 1997
2. Tamemoto H, Kadowaki T, Tobe K, Yagi T, Sakura H, Hayakawa T, Terauchi Y, Ueki K, Kaburagi Y, Satoh S, Sekihara H, Yoshioka S, Horikoshi H, Furuta Y, Ikawa Y, Kasuga M, Yazaki Y, Aizawa S: Insulin resistance and growth retardation in mice lacking insulin receptor substrate-1. Nature 372:182-186, 1994
3. Araki E, Lipes MA, Patti ME, Bruning JC, Haag B III, Johnson RS, Kahn CR: Alternative pathway of insulin signalling in mice with targeted disruption of the IRS-1 gene. Nature 372:186-190, 1994
4. Bruning JC, Winnay J, Bonner-Weir S, Taylor SI, Accili D, Kahn CR: Development of a novel polygenic model of NIDDM in mice heterozygous for IR and IRS-I null alleles. Cell 88:561-572, 1997
5. Withers DJ, Gutierrez JS, Towery H, Burks DJ, Ren JM, Previs S, Zhang Y, Bernal D, Pons S, Shulman GI, Bonner-Weir S, White MF: Disruption of IRS-2 causes type 2 diabetes in mice. Nature 391:900-904, 1998
6. Saad MJA, Araki E, Miralpeix M, Rothenberg PL, White MF, Kahn CR: Regulation of insulin receptor substrate 1 in liver and muscle of animal models of insulin resistance. J Clin Invest 90:1839-1849, 1992
7. Goodyear LJ, Giorgino F, Sherman LA, Carey J, Smith RJ, Dohm GL: Insulin receptor phosphorylation, insulin receptor substrate-1 phosphorylation, and phosphatidylinositol 3-kinase activity are decreased in intact skeletal muscle strips from obese subjects. J Clin Invest 95:2195-2204, 1995
8. Anai M, Funaki M, Ogihara T, Terasaki J, Inukai K, Katagiri H, Fukushima Y, Yazaki Y, Kikuchi M, Oka Y, Asano T: Altered expression levels and impaired steps in the pathway to phosphatidylinositol 3-kinase activation via insulin receptor substrates 1 and 2 in Zucker fatty rats. Diabetes 47:13-23, 1998
9. Kerouz NJ, Horsch D, Pons S, Kahn CR: Differential regulation of insulin receptor substrates-1 and -2 (IRS-I and IRS-2) and phosphatidylinositol 3-kinase isoforms in liver and muscle of the obese diabetic (ob/ob) mouse. J Clin Invest 100:3164-3172, 1997
10. Ricort JM, Tanti JF, Van Obberghen E, Le Marchand-Brustel Y: Alterations in insulin signalling pathway induced by prolonged insulin treatment of 3T3-L1 adipocytes. Diabetologia 38:1148-1156, 1995
11. Rondinone CM, Wang LM, Lonnroth P, Wesslau C, Pierce JH, Smith U: Insulin receptor substrate (IRS) 1 is reduced and IRS-2 is the main docking protein for phosphatidylinositol 3-kinase in adipocytes from subjects with non-insulin-dependent diabetes mellitus. Proc Natl Acad Sci U S A 94:4171-4175, 1997
12. Rice KM, Turnbow MA, Garner CW: Insulin stimulates the degradation of IRS-1 in 3T3-L1 adipocytes. Biochem Biophys Res Commun 190:961-967, 1993
13. Smith LK, Bradshaw M, Croall DE, Garner CW: The insulin receptor substrate (IRS-1) is a PEST protein that is susceptible to calpain degradation in vitro. Biochem Biophys Res Commun 196:767-772, 1993
14. Kettelhut IC, Wing SS, Goldberg AL: Endocrine regulation of protein breakdown in skeletal muscle. Diabetes Metab Rev 4:751-772, 1988
15. Dice JF: Molecular determinants of protein half-lives in eukaryotic cells (published erratum appears in FASEB J 2:2262, 1988). FASEB J 1:349-357, 1987
16. Smith LK, Rice KM, Garner CW: The insulin-induced down-regulation of IRS-1 in 3T3-L1 adipocytes is mediated by a calcium-dependent thiol protease. Mol Cell Endocrinol 122:81-92, 1996
17. Ciechanover A: The ubiquitin-proteasome proteolytic pathway. Cell 79:13-21, 1994
18. Sun XJ, Miralpeix M, Myers MG Jr, Glasheen EM, Backer JM, Kahn CR, White MF: The expression and function of IRS-1 in insulin signal transmission. J Biol Chem 267:22662-22672, 1992
19. Rice KM, Lienhard GE, Garner CW: Regulation of the expression of pp160, a putative insulin receptor signal protein, by insulin, dexamethasone, and 1-methyl-3-isobutylxanthine in 3T3-L1 adipocytes. J Biol Chem 267:10163-10167, 1992
20. Sun XJ, Wang LM, Zhang Y, Yenush L, Myers MG Jr, Glasheen EM, Lane WS, Pierce JH, White MF, Glasheen E, Lane WS: Role of IRS-2 in insulin and cytokine signalling. Nature 377:173-177, 1995
21. Fenteany G, Standaert RF, Lane WS, Choi S, Corey EJ, Schreiber SL: Inhibition of proteasome activities and subunit-specific amino-terminal threonine modification by lactacystin. Science 268:726-731, 1995
22. Fenteany G, Schreiber SL: Lactacystin, proteasome function, and cell fate. J Biol Chem 273:8545-8548, 1998
23. Dick LR, Cruikshank AA, Destree AT, Grenier L, McCormack TA, Melandri FD, Nunes SL, Palombella VJ, Parent LA, Plamondon L, Stein RL: Mechanistic studies on the inactivation of the proteasome by lactacystin in cultured cells. J Biol Chem 272:182-188, 1997
24. Dick LR, Cruikshank AA, Grenier L, Melandri FD, Nunes SL, Stein RL: Mechanistic studies on the inactivation of the proteasome by lactacystin: a central role for clasto-lactacystin beta-lactone. J Biol Chem 271:7273-7276, 1996
25. Pickart CM: Targeting of substrates to the 26S proteasome. FASEB J 11: 1055-1066, 1997
26. Murakami Y, Matsufuji S, Kameji T, Hayashi S, Igarashi K, Tamura T, Tanaka K, Ichihara A: Ornithine decarboxylase is degraded by the 26S proteasome without ubiquitination. Nature 360:597-599, 1992
27. Krappmann D, Wulczyn FG, Scheidereit C: Different mechanisms control signal-induced degradation and basal turnover of the NF-kappaB inhibitor IkappaB alpha in vivo. EMBO J 15:6716-6726, 1996
28. White MF: The IRS-signalling system in insulin and cytokine action (Review). Proc R Soc Lind B Biol Sci 351:181-189, 1996
29. Koopmans SJ, Ohman L, Haywood JR, Mandarino LJ, DeFronzo RA: Seven days of euglycemic hyperinsulinemia induces insulin resistance for glucose metabolism but not hypertension, elevated catecholamine levels, or increased sodium retention in conscious normal rats. Diabetes 46:1572-1578, 1997
30. Del Prato S, Leonetti F, Simonson DC, Sheehan P, Matsuda M, DeFronzo RA: Effect of sustained physiologic hyperinsulinaemia and hyperglycaemia on insulin secretion and insulin sensitivity in man. Diabetologia 37:1025-1035, 1994
31. Thomsom MJ, Williams MG, Frost SC: Development of insulin resistance in 3T3-L1 adipocytes. J Biol Chem 272:7759-7764, 1997
32. Tanti JF, Gremeaux T, Van Obberghen E, Le Marchand-Brustel Y: Serine/ threonine phosphorylation of insulin receptor substrate 1 modulates insulin receptor signaling. J Biol Chem 269:6051-6057, 1994
33. Mothe I, Van Obberghen E: Phosphorylation of insulin receptor substrate-1 on multiple serine residues, 612, 662, and 731 modulates insulin action. J Biol Chem 271:11222-11227, 1996
34. Tanti JF, Gremeaux T, Van Obberghen E, Le Marchand-Brustel Y: Effects of okadaic acid, an inhibitor of protein phosphatases-1 and -2A, on glucose transport and metabolism in skeletal muscle. J Biol Chem 266:2099-2103, 1991
35. Qiao L, Goldberg JL, Russell JC, Sun XJ: Identification of enhanced serine kinase activity in insulin resistance. J Biol Chem 274:10625-10632, 1999
36. Coux O, Tanaka K, Goldberg AL: Structure and functions of the 20S and 26S proteasomes. Annu Rev Biochem 65:801-847, 1996
37. Sozzani P, Hasan L, Seguelas MH, Caput D, Ferrara P, Pipy B, Cambon C: IL-13 induces tyrosine phosphorylation of phospholipase C gamma-1 following IRS-2 association in human monocytes: relationship with the inhibitory effect of IL-13 on ROI production. Biochem Biophys Res Commun 244: 665-670, 1998
38. Larsen CN, Finley D: Protein translocation channels in the proteasome and other proteases. Cell 91:431-434, 1997
39. Jariel-Encontre I, Pariat M, Martin F, Carillo S, Salvat C, Piechaczyk M: Ubiquitinylation is not an absolute requirement for degradation of c-Jun protein by the 26 S proteasome. J Biol Chem 270:11623-11627, 1995
40. Murakami Y, Hayashi S: Role of antizyme in degradation of ornithine decarboxylase in HTC cells. Biochem J 226:893-896, 1985
41. Li X, Coffino P: Distinct domains of antizyme required for binding and proteolysis of omithine decarboxylase. Mol Cell Biol 14:87-92, 1994
42. La X, Coffino P: Degradation of ornithine decarboxylase: exposure of the C-terminal target by a polyamine-inducible inhibitory protein. Mol Cell Biol 13:2377-2383, 1993
43. Li X, Stebbins B, Hoffman L, Pratt G, Rechsteiner M, Coffino P: The N terminus of antizyme promotes degradation of heterologous proteins. J Biol Chem 271:4441-4446, 1996
44. Smith LK, Vlahos CJ, Reddy KK, Falck JR, Garner CW: Wortmannin and LY294002 inhibit the insulin-induced down-regulation of IRS-1 in 3T3-L1 adipocytes. Mol Cell Endocrinol 113:73-81, 1995